Tear Trough Filler: Why It's the Riskiest Filler Area on the Face

Anatomy

Why the Tear Trough Is Anatomically Risky

The infraorbital area has unusually thin skin, minimal subcutaneous fat, a complex vascular network, and direct anatomic connections (through anastomoses with the dorsal nasal and supratrochlear arteries) to the ophthalmic and retinal circulation.

The tear trough itself is a ligamentous depression at the inferior orbital rim — not a hollow that simply needs filling. Volume in the wrong plane produces edema, lump, and discoloration. Volume in the wrong vessel produces ischemia and, in rare cases, vision loss.

Complications

The Specific Complications Patients Should Know About

• ·Tyndall effect: superficial HA placement produces a bluish discoloration visible through thin skin. Often persistent until dissolved.
• ·Persistent malar edema: filler in the wrong compartment can attract water and produce visible swelling that lasts months or years, sometimes requiring hyaluronidase or surgical revision.
• ·Palpable or visible lumps: especially with overcorrection or non-uniform placement.
• ·Migration: HA can migrate downward over time, producing a malar mound or unnatural contour that wasn't visible at the consult.
• ·Vascular occlusion: rare but reported. Can produce skin necrosis or — in the worst case via retinal artery embolization — partial or complete vision loss. This is a true ophthalmologic emergency.
• ·Chronic low-grade inflammation: nodules, biofilm, or delayed-onset inflammatory reactions can present months after treatment.

Patient selection

Who Is and Isn't a Good Candidate

Good candidates: shallow-to-moderate hollows with good skin quality, minimal festoons, no significant fat pseudoherniation, and realistic expectations.

Poor candidates: significant fat pad herniation (a surgical fix is more appropriate), pre-existing malar mounds, thyroid eye disease or significant fluid retention, very thin or dark-circle-driven appearance (a pigmentation issue, not a volume issue), and any patient who has had multiple prior filler sessions in the area that they have not had dissolved.

A useful self-check: pinch the lower lid skin gently. If it tents easily or shows significant laxity, surgical evaluation is more appropriate than filler.

Alternatives

Alternatives That Are Often Better

• ·Lower blepharoplasty with fat repositioning: the gold standard when the hollow is paired with fat pseudoherniation. Definitive, surgical, longer-lasting.
• ·Polynucleotide skin boosters or PRP: for crepey, thin, dark under-eye skin where the problem is skin quality, not volume.
• ·Mid-cheek volumization rather than direct tear trough fill: supporting the medial cheek often softens the hollow without injecting the tear trough directly.
• ·Lasers and topical retinoids: for pigmentation-driven dark circles that filler cannot address.
• ·Concealer and acceptance: not a punchline. For mild concerns, especially in patients with poor candidacy, the right answer is sometimes to not inject.

Operator selection

How to Choose an Injector for This Area

Operator skill dominates outcomes here more than in any other facial area. The right operator is a board-certified dermatologist, oculoplastic surgeon, or plastic surgeon with explicit, high-volume experience in periorbital filler.

Ask: how many tear troughs do you treat per month, what product do you use and why, what is your complication rate, do you keep hyaluronidase on site, and what is your protocol for suspected vascular event?

If the answers are vague, or the offer comes from a non-physician treatment-room injector with a discount package, decline. There is no urgency here that should override operator selection.